Fundraising Fox

Lipidiopharma

San Diego, US · Founded 2019 · 1 known investors

lipidiopharma.com ↗

Lipidio Pharma is developing a drug that targets the skin's endocrine signaling mechanisms to produce systemic effects such as weight and total body fat reduction. The company focuses on obesity treatment through this skin-based precision targeting approach.

Biotech

Founders & leadership

DB
David BulloughDirector
DP
Daniel PetreeDirector
JG
J. Gordon FoulkesExecutive Officer, Director

Investors · 1

3E Bioventures CapitalPalo Alto

Reported raises · per SEC filings

Form D private placements
▶$4.6MraisedNov 2019 · 58 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • David BulloughDirector
  • Daniel PetreeDirector
  • J. Gordon FoulkesExecutive Officer, Director
Offering amount
$12M
Amount sold
$4.6M
Sales commissions
$462.3K
Placement agents
Maxim Group LLC
First sale
Nov 2019
Incorporated
Corporation, Delaware, 2019
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.